Lance is a Venture Partner at Ysios and serves on the board of Oxthera.
He has over 20 years of experience in big pharma and small biotech start-up space. Prior to joining Ysios, Lance was Chief Medical Officer and Senior Vice President at Relypsa in the San Francisco Bay area where he was responsible for building and leading the Company’s clinical development, medical affairs and drug safety functions; as well as playing a key role in the preparation and execution of the Company’s fund-raising initiatives including the Company’s IPO. Under his clinical leadership, the Company secured FDA and EMA approval for Veltassa®. In addition to having worked across multiple therapeutic areas in clinical development, he has also worked closely with commercial teams to secure product reimbursement and to plan and execute product launches.
Lance received his Bachelor of Medicine and Bachelor of Surgery degree from the University of Cape Town, South Africa and holds a MSc (Pharmaceutical Medicine).